Skip to main content
TITAN PHARMACEUTICALS INC logo

TITAN PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · TTNP ISIN · US8883146065 LEI · 549300NOUZGB2ZNVJ794 US Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2020-09-14 Declaration of Voting R…
Country US United States of America
Listing US TTNP

About TITAN PHARMACEUTICALS INC

https://www.titanpharm.com/

Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics using its clinically proven ProNeura® technology, a long-term, continuous drug delivery platform. This platform is designed for the administration of medicines to treat select chronic diseases. The ProNeura system involves a small, solid implant that is placed subdermally and provides continuous, non-fluctuating blood levels of a drug for an extended period. The company's development efforts have historically focused on treatments for central nervous system disorders.

Recent filings

Filing Released Lang Actions
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated September 14, 2020, by Titan Pharmaceuticals, Inc. It primarily discusses the submission of matters to a vote of security holders regarding a special meeting to approve an amendment to increase authorized shares. It includes details about voting results and meeting adjournments. The content focuses on shareholder voting results and meeting updates rather than the full proxy statement or solicitation materials themselves. The document also references a Definitive Proxy Statement filed earlier but does not contain the proxy materials themselves. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports official results from shareholder votes at a meeting. The document length is under 5,000 characters, but it contains substantive voting results, not just an announcement of a report publication. Therefore, the correct classification is DVA with high confidence.
2020-09-14 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The content focuses on the submission of matters to a vote of security holders, specifically regarding the adjournment and resumption of a special meeting to vote on an amendment to increase authorized shares. It provides details about the voting process and record date shares. This corresponds to an official announcement of voting results or voting rights matters. The document is relatively short (4476 characters) and does not contain detailed financial statements or management discussion, so it is not an Annual Report or Interim Report. It is not a proxy solicitation or presentation but an announcement of voting results. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-09-01 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by Titan Pharmaceuticals, Inc. It primarily discusses the submission of matters to a vote of security holders related to a special meeting to approve an amendment to increase authorized shares. It includes details about the voting process, record date, and adjournment of the meeting. The key content is the official results and procedural information about shareholder voting. There is no financial data, earnings information, or detailed report content. The document fits the description of Declaration of Voting Results & Voting Rights Announcements (DVA) as it reports on shareholder vote matters and results. The document length is 4480 characters, which is consistent with a detailed voting results announcement rather than a full report or proxy statement. Therefore, the classification is DVA with high confidence.
2020-09-01 English
FORM 8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The key content is under Item 3.01, which is a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The document discusses the company's non-compliance with Nasdaq's minimum stockholders' equity requirement and the steps being taken to regain compliance. There is no detailed financial data or full report included, just an announcement of the delisting risk and related corporate actions. The document length is 4357 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as a Delisting Announcement (DLST).
2020-08-20 English
FORM 10-Q
Interim / Quarterly Report Q2 2020
2020-08-14 English
FORM 8-K/A
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K/A, which is an amendment to a previously filed Form 8-K. It specifically amends the date of a Special Meeting and provides details about the submission of matters to a vote of security holders, including information about a proposal to amend the certificate of incorporation to increase authorized shares. The content focuses on shareholder voting results and meeting adjournment details, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements. The document is not a full financial report, earnings release, or proxy solicitation, but rather an official announcement of voting results and related meeting information. Therefore, the appropriate classification is DVA (Declaration of Voting Results & Voting Rights Announcements). The document length and content support a high confidence in this classification.
2020-08-13 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.